本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

COEPTIS THERAPEUTICS HOLDINGS INC

15.22
-0.0700-0.46%
盘后15.220.00000.00%16:10 EDT
成交量:2.70万
成交额:40.80万
市值:7,336.50万
市盈率:-3.97
高:15.48
开:15.48
低:14.75
收:15.29
52周最高:19.19
52周最低:2.31
股本:482.03万
流通股本:419.82万
量比:0.99
换手率:0.64%
股息:- -
股息率:- -
每股收益(TTM):-3.8309
每股收益(LYR):-5.0989
净资产收益率:-372.11%
总资产收益率:-98.25%
市净率:12.04
市盈率(LYR):-2.98

数据加载中...

2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/03

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/28

重要事件披露

Form 8-K - Current report
2025/04/18

SEC问询函

Form CORRESP - Correspondence
2025/04/04

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/24

重要事件披露

Form 8-K - Current report
2025/01/22

重要事件披露

Form 8-K - Current report
2025/01/10

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/27

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/17

重要事件披露

Form 8-K - Current report
2024/12/05

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report